DelveInsight’s “Chronic Kidney Disease Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Chronic Kidney Disease pipeline landscapes.
The report comprises Chronic Kidney Disease pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Chronic Kidney Disease therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Chronic Kidney Disease pipeline products.
Some of the key takeaways from the Chronic Kidney Disease Pipeline Report:
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as GlaxoSmithKline, Akebia Therapeutics, FibroGen/ Astellas Pharma/ AstraZeneca, Boehringer Ingelheim, Astra Zeneca, Tricida, Reata Pharmaceuticals, Corvidia Therapeutics, etc., are developing therapies for the treatment of Chronic Kidney Disease.
Emerging therapies such asDaprodustat, Vadadustatm, Roxadustat, Empagliflozin, Dapagliflozin, Veverimer, Bardoxolone Methyl, Ziltivekimab, are expected to have a significant impact on the Chronic Kidney Disease market in the coming years.
Get an overview of pipeline landscape @ Chronic Kidney Disease Clinical Trials Analysis
Chronic kidney disease (CKD) means your kidneys are damaged and can’t filter blood the way they should. The disease is called “chronic” because the damage to your kidneys happens slowly over a long period of time. This damage can cause wastes to build up in your body.
Chronic Kidney Disease Pipeline Therapies along with Key Players:
Daprodustat by GlaxoSmithKline
Vadadustat by Akebia Therapeutics
Roxadustat by FibroGen/ Astellas Pharma/ AstraZeneca
Empagliflozin by Boehringer Ingelheim
Dapagliflozin by Astra Zeneca
Veverimer by Tricida
Bardoxolone Methyl by Reata Pharmaceuticals
Ziltivekimab by Corvidia Therapeutics
And others.
Scope of Chronic Kidney Disease Pipeline Drug Insight
Coverage: Global
Major Players: GlaxoSmithKline, Akebia Therapeutics, FibroGen/ Astellas Pharma/ AstraZeneca, Boehringer Ingelheim, Astra Zeneca, Tricida, Reata Pharmaceuticals, Corvidia Therapeutics, and others.
Pipeline Therapies: Daprodustat, Vadadustatm, Roxadustat, Empagliflozin, Dapagliflozin, Veverimer, Bardoxolone Methyl, Ziltivekimab, and others.
Table of Contents
1
Chronic Kidney Disease Report Introduction
2
Chronic Kidney Disease Executive Summary
3
Chronic Kidney Disease Overview
4
Chronic Kidney Disease- Analytical Perspective In-depth Commercial Assessment
5
Chronic Kidney Disease Pipeline Therapeutics
6
Chronic Kidney Disease Late Stage Products (Phase II/III)
7
Chronic Kidney Disease Mid Stage Products (Phase II)
8
Chronic Kidney Disease Early Stage Products (Phase I)
9
Chronic Kidney Disease Preclinical Stage Products
10
Chronic Kidney Disease Therapeutics Assessment
11
Chronic Kidney Disease Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Chronic Kidney Disease Key Companies
14
Chronic Kidney Disease Key Products
15
Chronic Kidney Disease Unmet Needs
16
Chronic Kidney Disease Market Drivers and Barriers
17
Chronic Kidney Disease Future Perspectives and Conclusion
18
Chronic Kidney Disease Analyst Views
19
Appendix
20
About DelveInsight
Related Reports:
Chronic Kidney Disease Market
DelveInsight’s “Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Chronic Kidney Disease Epidemiology
DelveInsight’s ‘Chronic Kidney Disease – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Kidney Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/